Breast Cancer Clinical Trial
Official title:
Does a Peer Navigator Improve Quality of Life at Diagnosis?
| Verified date | September 2005 |
| Source | Stanford University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Women indicate the greatest needs for counseling at the time of initial diagnosis for primary
breast cancer. The time of initial diagnosis is also often the time of greatest need for
information for women and their families. However, this is the time when a woman, overwhelmed
by shock and trauma, is least likely to absorb information provided or seek new sources of
information. An informed peer navigator with carefully trained communication skills can judge
the level of information to disclose and pace that information in a way that can be easily
absorbed and understood. She will also provide support. WomenCARE, a well-established Santa
Cruz agency providing free support services for women with cancer, and the Psychosocial
Treatment Lab at Stanford therefore ask whether women newly diagnosed with breast cancer will
improve their quality of life by participating in a peer navigator program. WomenCARE's peer
navigators provide emotional support, good listening skills, and information on resources for
women just diagnosed with breast cancer. Having a peer counselor while a woman goes through
treatment may reduce the magnitude of distress or shorten its time course. It may also reduce
distress in family members, and improve relationships with medical personnel.
This study is designed to evaluate the effectiveness of a peer navigator program where a
woman newly diagnosed with breast cancer is carefully matched for 3 to 6 months after
diagnosis with a trained volunteer who is herself a breast cancer survivor. Navigators and
Sojourners (newly diagnosed women) are matched on things that are important to them. Women
often want to be matched on the type of surgery or treatment they have received. We assign
half of the women (by a process similar to a coin toss) to our peer navigator program and
half to a group that receives standard medical care but no peer navigator. In this way we can
compare the groups to see whether those matched with a peer navigator have better quality of
life over the 3 to 6 month period. All women who join our study, regardless of the group to
which they are assigned, get an extra consultation with a nurse specialist at a local
hospital. In this consultation, the nurse reviews the cancer resources available to the woman
in Santa Cruz County. This meeting is tailored to the woman's individual diagnosis and
situation.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | November 30, 2006 |
| Est. primary completion date | November 30, 2006 |
| Accepts healthy volunteers | |
| Gender | Female |
| Age group | 20 Years to 85 Years |
| Eligibility |
Inclusion Criteria: women within 2 months of diagnosis of breast cancer can read English within the catchment area of Watsonville and Santa Cruz California - Exclusion Criteria: women who have previously had a peer navigator intervention women who have a chronic history of hospitalization for psychiatric reason - |
| Country | Name | City | State |
|---|---|---|---|
| United States | WomenCARE | Santa Cruz | California |
| Lead Sponsor | Collaborator |
|---|---|
| Stanford University | Amgen, California Breast Cancer Research Program, Genentech, Inc., Google Inc., Johnson & Johnson |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |